BrightPath Biotherapeutics Co., Ltd. Stock
Equities
4594
JP3274140007
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
57 JPY | -1.72% | -3.39% | -34.48% |
Sales 2017 | 529M 3.37M | Sales 2018 | 354M 2.26M | Capitalization | 33.68B 215M |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.1M | Net income 2018 | -1.58B -10.06M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 31.58M | Net cash position 2018 | 6.53B 41.64M | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.53% |
1 day | -1.72% | ||
1 week | -3.39% | ||
Current month | -5.00% | ||
1 month | -5.00% | ||
3 months | -30.49% | ||
6 months | -41.24% | ||
Current year | -34.48% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 15-05-31 | |
Akira Yamada
BRD | Director/Board Member | 67 | 03-04-30 |
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-26 | 57 | -1.72% | 392 100 |
24-05-24 | 58 | 0.00% | 227,500 |
24-05-23 | 58 | -1.69% | 307,400 |
24-05-22 | 59 | -1.67% | 207,800 |
24-05-21 | 60 | +1.69% | 166,000 |
Delayed Quote Japan Exchange, May 26, 2024 at 10:22 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-34.48% | 26.22M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- 4594 Stock